SENOLYS Trademark

Trademark Overview

On Friday, March 19, 2021, a trademark application was filed for SENOLYS with the United States Patent and Trademark Office. The USPTO has given the SENOLYS trademark a serial number of 90591143. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Seragon Pharmaceuticals Inc.. The SENOLYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
senolys

General Information

Serial Number90591143
Word MarkSENOLYS
Filing DateFriday, March 19, 2021
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7208145
Registration DateTuesday, October 31, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 23, 2021
Primary Code005
First Use Anywhere DateWednesday, May 31, 2023
First Use In Commerce DateWednesday, May 31, 2023

Trademark Owner History

Party NameSeragon Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSeragon Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSeragon Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Saturday, August 21, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 23, 2021NEW APPLICATION ENTERED
Wednesday, June 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 20, 2021ASSIGNED TO EXAMINER
Saturday, August 21, 2021NON-FINAL ACTION E-MAILED
Saturday, August 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 4, 2022SUSPENSION LETTER WRITTEN
Friday, February 4, 2022LETTER OF SUSPENSION E-MAILED
Friday, February 4, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 5, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 24, 2023DIVISIONAL REQUEST RECEIVED
Thursday, August 24, 2023USE AMENDMENT FILED
Thursday, August 24, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, August 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 5, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 28, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 29, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 9, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 9, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 9, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

senolys gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related